BridgeMD
New treatment option for End Stage Renal Disease
Official title Impact on Quality of Life of Symptoms Routine E-monitoring Among Dialysis Patients.
ClinicalTrials.gov ID: NCT06257134
What this study is testing
- What it's testing
- In France, end-stage renal disease (ESRD) affects almost 170 people per million inhabitants every year, and 92,500 people are treated by dialysis or kidney transplantation (0.14% of the French population). The treatment of chronic renal failure is extremely costly: 4 billion euros in 2021, i.e.
- Time commitment: about 10 years
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older. Healthy volunteers may be eligible.
You may be able to join if
- Symptom collection phase The for patients are as follows:
- Individuals who have received full information on the organization of the research and who have not objected to their participation and to the use of...
- Adults aged 18 and over
- Patients with end-stage renal disease treated by dialysis in participating dialysis units
- Patients able to answer questionnaires Process evaluation phase The for healthcare professionals are as follows:
You likely can't join if
- The non-inclusion criteria for patients are as follows:
- Minors
- Patients under legal protection, guardianship or curatorship
- Patient not communicating or unable to give consent
- Patient not being treated in a dialysis unit participating in the study
- Patients being treated temporarily in a participating dialysis unit (respite care, vacationers, etc.)
See the full eligibility criteria
- Symptom collection phase The for patients are as follows:
- Individuals who have received full information on the organization of the research and who have not objected to their participation and to the use of their data.
- Adults aged 18 and over
- Patients with end-stage renal disease treated by dialysis in participating dialysis units
- Patients able to answer questionnaires Process evaluation phase The for healthcare professionals are as follows:
- Individuals who have received full information on the organization of the research and who have not objected to their participation and to the use of their data.
- Patients with end-stage renal disease treated by dialysis in participating dialysis units.
- Doctors and nurses working in the dialysis unit taking part in the study.
- The non-inclusion criteria for patients are as follows:
- Minors
- Patients under legal protection, guardianship or curatorship
- Patient not communicating or unable to give consent
- Patient not being treated in a dialysis unit participating in the study
- Patients being treated temporarily in a participating dialysis unit (respite care, vacationers, etc.)
- Patient with cognitive disorders
- Patient unable or unwilling to answer questionnaires The non-inclusion criteria for healthcare professionals are as follows:
- Non-voluntary healthcare professional
- Healthcare professional not working in the participating facility
The study team makes the final eligibility decision.
Where it's taking place
- Gradignan, France
- Vandœuvre-lès-Nancy, France
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The study runs about 10 years per participant, based on its public description. The team confirms the exact schedule and number of visits before you enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Gradignan, France; Vandœuvre-lès-Nancy, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.